C R. KAHN, M.D.

Plain English
This study looked at how changes in brain cells called astrocytes affect feelings of anxiety, depression, and motivation for rewards in mice. Researchers found that removing a specific protein from these cells led to higher anxiety and depressive behaviors, along with a lower desire for rewards—especially in female mice. This matters because it highlights how astrocytes influence the brain's dopamine system, which is important for mood and motivation. Who this helps: This helps patients with anxiety and depression.

Plain English
This study focused on a protein called Lrtm1, which is involved in how muscles respond to insulin. The researchers found that mice lacking Lrtm1 had 15% less body fat, 10% more lean muscle, and showed better glucose and insulin response than normal mice. Understanding Lrtm1's role is important because it could lead to new insights into how to manage metabolism and related conditions like obesity and diabetes. Who this helps: This helps patients with obesity and diabetes.

Plain English
This study looked at how insulin signaling works differently in liver cells from people with type 2 diabetes compared to those without the condition. Researchers found that over 300 parts of the insulin signaling process were less active and that more than 500 new or enhanced signaling pathways appeared in the liver cells of diabetic patients. This matters because it helps to understand the complex changes that cause insulin resistance in type 2 diabetes, revealing potential new targets for treatment. Who this helps: This research benefits patients with type 2 diabetes and healthcare providers working on treatment options.

Plain English
This study examined the role of insulin signaling in brain cells called microglia, which help clean up harmful substances like a protein linked to Alzheimer's disease (AD). Researchers created special mice that had reduced insulin signaling in these microglia and found that this led to impaired uptake of the Alzheimer-related protein amyloid-beta (Aβ) and increased neuroinflammation, which worsened AD-like symptoms, as shown by increased Aβ levels and changes in mood and social behavior. Understanding this process is important because targeting insulin signaling in microglia could offer a new way to treat Alzheimer's disease. Who this helps: This benefits patients with Alzheimer's disease and their families.

Plain English
This study looked at a protein called Protein Kinase C δ (PKC δ) and its role in immune cells called macrophages during infections. Researchers found that when PKC δ was removed from macrophages in mice, the lungs had a stronger immune response that led to more neutrophils (a type of white blood cell) but fewer inflammatory macrophages, which made the infection worse. They discovered that boosting PKC δ or adding a substance called GM-CSF helped improve the macrophages' ability to fight bacteria. Who this helps: This research benefits patients with infections by identifying ways to enhance immune responses.

Plain English
This study examined how substances produced by gut bacteria (metabolites) affect insulin resistance and obesity in mice, particularly focusing on how these substances are distributed in the bloodstream. They found that mice prone to obesity had 111 metabolites higher in the portal blood compared to 74 in the peripheral blood, and treatment with an antibiotic altered these levels, improving insulin signaling and metabolism. This research shows that the balance of these metabolites is crucial for understanding and potentially addressing insulin resistance linked to diet. Who this helps: This helps patients at risk of type 2 diabetes and obesity, as well as their doctors.

Plain English
Ten people with obesity and type 2 diabetes underwent marked weight loss of 16–20%, which more than doubled their whole-body insulin sensitivity. The improvements were accompanied by reduced fat tissue scarring signals, lower levels of a clotting-related protein (PAI-1), and a dramatic decrease in tiny fat-cell particles that block insulin signaling in muscle. The findings point to changes in fat tissue biology — not just less fat mass — as a key reason weight loss restores insulin action.

Plain English
Researchers studied how insulin resistance interacts with genetics and the donor's sex to affect gene activity in muscle cells made from stem cells. They found that people with insulin resistance had 306 genes that were more active and 271 genes that were less active compared to those without insulin resistance. Some of these gene changes were linked to the risk of developing type 2 diabetes and were influenced by whether the donor was male or female. Who this helps: This research can benefit patients at risk for type 2 diabetes and their doctors by improving understanding of how genetics and sex influence insulin resistance.

Plain English
This study looked at how two types of cells—fibroadipogenic progenitors (FAPs) and muscle stem cells (MuSCs)—communicate and work together during muscle recovery after injury. The researchers found that after an injury, FAPs release tiny particles filled with specific microRNAs, including one called miR-127-3p, which helps muscles heal faster. This process not only boosts muscle regeneration but also prevents excessive fat buildup in the muscles. Who this helps: This benefits patients recovering from muscle injuries, such as athletes or anyone undergoing rehabilitation.

Plain English
This study investigated how insulin affects the release of tiny molecules called microRNAs (miRNAs) from fat cells into small extracellular vesicles, which can influence how other cells behave. The researchers found that insulin increased the secretion of 53 miRNAs while reducing 66 others from fat cells, but only 12 of those changes also happened inside the cells. Notably, 43% of the miRNAs affected by insulin are linked to obesity and insulin resistance, highlighting how insulin influences fat tissue and metabolism. Who this helps: This helps patients with obesity and insulin resistance, as well as their doctors, by providing insights into how insulin functions in the body.

Plain English
This study looked at how insulin signaling in microglia, the brain's immune cells, affects their ability to manage proteins linked to Alzheimer's disease, particularly amyloid-beta (Aβ). Researchers found that when insulin signaling is disrupted in these cells, it leads to changes in gene expression and metabolism, impairing their ability to remove Aβ, which increases neuroinflammation and worsens symptoms related to Alzheimer's. Specifically, the altered mice showed higher levels of Aβ and changes in mood and social behavior, indicating that insulin signaling is important for both brain health and the progression of Alzheimer's. Who this helps: Patients with Alzheimer's disease and their caregivers.

Plain English
This study looked at how a liver protein called SerpinA1 affects fat cells and metabolism in mice recovering from a fat distribution disorder. They found that higher levels of SerpinA1 led to increased growth of fat precursor cells and enhanced energy-burning processes, which improved overall fat levels and blood sugar management in these mice. Specifically, mice with more SerpinA1 burned more energy and had better glucose control, while those without it became obese and had trouble with insulin. Who this helps: Patients with obesity and insulin resistance.

Plain English
This research studied how a specific amino acid, leucine-973, affects the way insulin and IGF-1 receptors signal in cells. When leucine-973 was changed to phenylalanine, the signaling became less efficient for glucose uptake and more focused on cell growth, resulting in decreased insulin sensitivity, increased growth, and less weight gain in mice on a high-fat diet. These findings help us understand how the insulin receptor functions differently from the IGF-1 receptor, which could inform future treatments for metabolic disorders. Who this helps: This benefits patients with insulin resistance and conditions like obesity and type 2 diabetes.

Plain English
This study looked at how the insulin receptor (IR), which usually responds to insulin, can also affect cell growth and death without this traditional signaling. Researchers discovered a new way the IR works that does not rely on insulin binding or its usual kinase activity, showing that this different pathway influences how cells grow, age, and die. Specifically, they found that activating this new pathway increases the production of certain proteins related to cell structure and decreases immune response proteins, suggesting a complex role for the insulin receptor beyond just managing sugar levels. Who this helps: This research benefits patients with metabolic disorders, as it offers insights into new treatment pathways.

Plain English
This study looked at the impact of fructose and high-fat diets on liver health, particularly how they lead to non-alcoholic fatty liver disease (NAFLD). Researchers found that a specific enzyme called KHK-C increases stress in liver cells when fructose is consumed with fatty foods, worsening liver damage. Reducing KHK-C in mice improved liver health, indicating that targeting this enzyme might help treat or prevent liver issues related to diet. Who this helps: This research benefits patients at risk for liver disease, particularly those with poor dietary habits.

Plain English
This study looked at how sugar, especially fructose, combined with a high-fat diet affects fat metabolism in mice. The researchers found that increased levels of an enzyme called ketohexokinase-C (KHK-C) led to changes in protein modifications that reduce the breakdown of fats, resulting in more fat storage. Specifically, higher KHK-C was associated with less of a protein called CPT1a, which is important for fat oxidation—showing a clear link between sugar intake and fat accumulation. Who this helps: This research benefits patients at risk of obesity and metabolic disorders, as well as doctors seeking better treatment options.

Plain English
This research studied how losing insulin signaling in specific brain cells called astrocytes affects Alzheimer's disease symptoms in a special breed of mice known for developing the disease. The researchers found that mice with disrupted insulin signaling showed worse behavior and brain changes, including larger amyloid plaques and increased tau protein levels, by six months of age compared to regular mice—specifically, their nesting behavior declined by significant amounts, and their performance on memory tests worsened. This finding is important because it highlights that insulin signaling in astrocytes could play a key role in Alzheimer's disease progression, suggesting new treatment options for people affected by both diabetes and Alzheimer’s. Who this helps: This helps patients with Alzheimer's disease and type 2 diabetes.

Plain English
This study looked at how eating a high-fat diet and consuming fructose can worsen non-alcoholic fatty liver disease (NAFLD), a condition affecting about one billion people worldwide. Researchers found that fructose processed through a specific enzyme (KHK-C) increases stress in liver cells, which contributes to liver damage, while reducing this enzyme improved liver health in mice. They also discovered that higher levels of this enzyme were linked to obesity and liver fat in both mice and humans, suggesting that controlling KHK-C could help prevent liver disease. Who this helps: This research benefits patients suffering from NAFLD and doctors seeking better treatment options.

Plain English
This research paper examines the link between insulin and liver diseases, particularly in people with obesity who often develop a condition called metabolic-associated fatty liver disease (MAFLD). It highlights that over 65% of obese individuals have MAFLD, which can lead to serious issues like liver inflammation, scarring, or cancer. The findings suggest that improving how the body responds to insulin might help manage this disease, especially in its later stages. Who this helps: This benefits patients with obesity and liver diseases, as well as their healthcare providers.

Plain English
This study examined how a protein called FoxK1 influences gene activity in the liver in response to insulin. Researchers found that FoxK1 links to over 4,000 genes, with insulin boosting its effects on about 75% of these genes, which are important for processes like metabolism and cell function. This research is significant because it highlights FoxK1's role in managing how the liver processes insulin, which is crucial for maintaining healthy blood sugar levels. Who this helps: This benefits patients with diabetes and metabolic disorders.

Plain English
This study looked at how a medication called rosiglitazone affects patients with secondary lymphedema, a condition that can occur after certain cancer surgeries and leads to swelling and tissue buildup in the limbs. The researchers found that rosiglitazone reduced the amount of fibrous and fat tissue in a mouse model, specifically decreasing the presence of certain cells involved in tissue growth by 30%. This is important because it shows that a drug designed to promote fat cell formation can actually help treat the buildup associated with lymphedema. Who this helps: This helps patients suffering from secondary lymphedema after cancer surgery.

Plain English
This study looked at tiny molecules called miRNAs found in the body, which help cells communicate and affect metabolism, especially in people with obesity. The researchers found that levels of these miRNAs change with obesity and can improve with weight loss through diet, exercise, or surgery. This is important because understanding these changes could help develop better treatments for obesity-related health issues. Who this helps: Patients struggling with obesity and related metabolic problems.

Plain English
This study examined how certain small molecules called microRNAs (miRNAs) are sorted for release into tiny bubbles that cells use to communicate with each other, known as small extracellular vesicles (sEVs). Researchers found that specific sequences in the miRNAs determine whether they are secreted into sEVs or kept inside the cell. For instance, the presence of a particular sequence increased the amount of miRNA released, which led to stronger effects on neighboring cells. Who this helps: This benefits doctors and researchers working on RNA-based therapies and understanding cell communication.

Plain English
This study looked at small extracellular vesicles (sEVs), which are tiny particles released by cells that can carry important information between them. Researchers found that different types of cells produce unique sets of proteins in their sEVs, with six specific proteins being commonly found across all tested cell types. By analyzing mice with changes in fat tissue, the study showed that these unique protein markers could help identify which type of tissue the sEVs in the bloodstream come from, which is important for understanding how metabolism works in the body. Who this helps: This helps doctors and researchers in understanding metabolic diseases and developing better diagnostics for patients.

Plain English
This study looked at how gut bacteria affect the pancreas and gut hormones in mice and humans. When mice ate a high-fat diet, their pancreas grew 40% larger and showed changes in hormone levels linked to diabetes. The researchers found that giving antibiotics changed these effects, and similar results were observed in obese men with prediabetes after treatment. Who this helps: Patients with obesity and prediabetes can benefit from insights into how gut bacteria influence their health.

Plain English
This study looked at how insulin works in the brain and the different types of brain cells involved. Researchers found that problems with insulin signaling in the brain can lead to various issues, including mood and thinking disorders. Understanding these mechanisms is important because it could lead to new treatments for these diseases. Who this helps: This helps patients with diabetes and neuropsychiatric conditions.

Plain English
This study looked at how long-term high insulin levels, often seen in obesity and metabolic disorders, can cause liver cells (hepatocytes) to age prematurely. The researchers found that chronic high insulin increased markers of aging in these liver cells, specifically boosting proteins like p53 and p21, which are linked to cell senescence. They discovered that blocking insulin signals could prevent this aging process, and certain drugs like dasatinib and quercetin could also help reduce the harmful effects of high insulin on liver cells. Who this helps: This helps patients with obesity and metabolic syndrome, as well as doctors treating liver-related conditions.

Plain English
This study looked at how certain proteins from gut bacteria may trigger type 1 diabetes (T1D) by mimicking parts of insulin, specifically a sequence called insB:9-23. Researchers found 17 gut microbial peptides similar to this insulin sequence, with one particular peptide that could activate immune cells linked to T1D in both mice and humans. They discovered that mice with this peptide developed more severe T1D symptoms, and children with gut bacteria capable of producing this peptide had higher rates of autoantibodies, which are indicators of T1D. Who this helps: This research benefits patients at risk for type 1 diabetes and doctors looking for better screening and preventive strategies.

Plain English
Researchers studied mice with a specific genetic modification that stopped the action of two proteins, Akt1 and Akt2, in their muscles. These modified mice lost muscle mass, became less active, developed weaker bones, and had a shorter lifespan, with many dying from muscle weakness or tumors. This shows that in mammals, disrupting insulin signaling in muscles can speed up aging and serious health problems. Who this helps: This could benefit patients with muscle and bone disorders, as well as doctors treating age-related conditions.

Plain English
This study looked at a protein called alpha4 (α4) and its role in how fat cells respond to insulin, which is important for managing blood sugar and fat levels. The researchers found that when α4 was removed from fat cells in male mice, the mice developed problems like difficulty storing fat, increased inflammation, and resistance to insulin, which are all linked to obesity and diabetes. These findings are important because they reveal how α4 is crucial for keeping insulin signaling in check and maintaining healthy metabolism. Who this helps: This helps patients with obesity and type 2 diabetes by improving the understanding of how insulin resistance develops.

Plain English
This study looked at a virus called Lymphocystis disease virus-1 (LCDV-1) and found that it produces a specific peptide (scLCDV1-VILP) that can block the activity of a receptor in human cells called IGF1R, which is involved in cell growth and division. The researchers discovered that scLCDV1-VILP effectively inhibits IGF-1 related cell growth in mice without affecting insulin signaling, making it a promising candidate for developing treatments for cancers and metabolic disorders tied to IGF-1, while preserving normal glucose metabolism. Who this helps: This findings benefits researchers and doctors working on cancer and metabolic disorder therapies.

Plain English
This study looks at the discovery of insulin 100 years ago and its huge impact on diabetes treatment and broader medical research. It highlights that insulin not only transformed how we manage diabetes, making it less deadly, but also sparked important research in many other areas of science. The findings emphasize that the advances stemming from insulin's discovery have often gone unrecognized, yet they have shaped the direction of modern biomedical science. Who this helps: This helps patients with diabetes and the doctors treating them.

Plain English
This study investigates how insulin action is impaired in people with type 2 diabetes, focusing on both external factors like lipids and amino acids and internal genetic changes in cells. Researchers found that both types of factors contribute to insulin resistance, affecting how the body processes sugars and fats. Understanding these issues can lead to better treatments and prevention strategies for type 2 diabetes. Who this helps: This helps patients with type 2 diabetes and those at risk of developing the disease.

Plain English
Researchers studied how insulin and insulin-like growth factor 1 (IGF-1) receptors send different signals within cells, even though they are similar. They found that insulin receptors mainly activate pathways related to cell growth and survival (mTORC1 and Akt), while IGF-1 receptors focus on pathways that control cell movement and division (Rho GTPases). This research reveals why these two hormones have different effects on the body: insulin helps regulate metabolism, while IGF-1 is more involved in growth and development. Who this helps: This benefits patients who rely on insulin and IGF-1 for managing metabolic and growth-related health issues.

Plain English
Researchers studied how insulin from the blood affects gene activity in key areas of the brain in mice. They found that higher insulin levels led to significant changes in the expression of many genes, especially in the hypothalamus, influencing neurotransmission and metabolism. This shift is important because it suggests that insulin plays a critical role in brain functions, and problems with this process might impact conditions like diabetes and overall health. Who this helps: This helps patients with diabetes and researchers studying brain health.

Plain English
This study looked at people with diabetes who are at risk of developing end-stage kidney disease (ESKD). Researchers analyzed blood samples from 1,121 individuals and found 17 specific molecules called miRNAs, which were linked to a higher chance of developing ESKD over the next 10 years. They also identified proteins in the blood that could indicate the severity of kidney damage, showing that certain miRNAs and proteins are key to understanding and potentially treating diabetic kidney disease. Who this helps: This research benefits patients with diabetes and doctors working to prevent kidney disease.

Plain English
This study looked at how insulin affects blood vessel cells in mice after an injury to their arteries. Researchers found that insulin helps limit the growth of problematic tissue inside the blood vessels (called neointima) when both types of cells—endothelial cells and smooth muscle cells—are responsive to insulin. Specifically, insulin reduced the neointimal area by about 30% in some mice, but had no impact when insulin receptors were only present in one type of cell. Who this helps: This research benefits patients with conditions that cause artery blockages, like heart disease.

Plain English
Researchers explored the history and progress made in understanding insulin over the past 100 years, focusing on its crucial role in managing blood sugar levels and its effects on various body tissues. They found that improvements in research have revealed not just how insulin works but also how many tissues throughout the body respond to it, which is important in understanding issues like type 2 diabetes. More discoveries are needed to fully harness this knowledge to improve treatments for diabetes and related conditions. Who this helps: This benefits patients with type 2 diabetes and healthcare providers treating these patients.

Plain English
This study looked at the role of specific microRNAs (tiny molecules that help control genes) in people with HIV who have a condition called lipodystrophy, which affects fat distribution in the body. Researchers found that in individuals with HIV lipodystrophy, a molecule called miR-20a-3p was higher, while miR-324-5p and miR-186 were lower, which linked to problems like fat redistribution and insulin resistance. This matters because understanding these changes can help develop treatments for metabolic issues associated with HIV lipodystrophy. Who this helps: This helps patients living with HIV who experience lipodystrophy.

Plain English
This study focused on a type of viral peptide called lymphocystis disease virus-1 (LCDV1)-VILP, which was found to block the human IGF-1 receptor, a protein involved in growth and metabolism. Researchers discovered that this peptide is a strong antagonist, meaning it can effectively shut down the receptor's activity, potentially offering new ways to treat diseases related to cell growth, like cancer. By modifying the structure of IGF-1, they even created a version that also acts as a powerful antagonist. Who this helps: This research benefits patients with conditions like cancer and other growth-related disorders.

Plain English
This study looked at how certain proteins called FOXO transcription factors affect how insulin works in different types of body fat, specifically brown and white fat. Researchers found that mice without insulin receptors and FOXO proteins had normal brown fat and better blood sugar control, but still struggled with some fat issues and insulin resistance. This is important because it shows that FOXO factors play a key role in how our body uses insulin, especially in regulating different types of fat and liver function. Who this helps: Patients with insulin resistance-related conditions such as diabetes and obesity.

Plain English
This research studied how certain changes in cell signals relate to insulin resistance in both healthy and diabetic individuals, finding that around 25% of the general population is affected. The study specifically identified key changes in proteins that play roles in insulin signaling, noting significant differences between men and women. This information is important because it helps to understand how insulin resistance develops and varies by sex, which could lead to more tailored treatments for patients. Who this helps: This helps patients with insulin resistance and diabetes, as well as doctors treating them.

Plain English
This study looked at how insulin and IGF-1 affect muscle health by regulating gene activity, particularly focusing on a group of proteins called FoxO. Researchers found that when both insulin and IGF-1 receptors were removed from muscle cells, over 3,000 genes were significantly affected, leading to problems with energy production and increased harmful molecules in muscle tissue. These changes are important because they highlight how crucial insulin and IGF-1 are for maintaining healthy muscle function, and point towards FoxO proteins as key players in these processes. Who this helps: This research benefits patients with muscle-related diseases and doctors treating them.